The combination of Merck's Welireg and Eisai's Lenvima has not yet shown statistical significance in extending overall ...

After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.

EDP-323 significantly reduced mean viral load AUC by 85% and 87% in the high- and low-dose groups, respectively, compared ...

Rare disease drug development presents unique challenges: patient populations are often minimal, clinical endpoints may not ...

The LITESPARK-022 and LITESPARK-011 trials evaluated combination regimens containing belzutifan in patients with advanced clear cell RCC.

The US Cybersecurity and Infrastructure Security Agency (CISA) has added a critical severity Motex Landscope Endpoint Manager ...

As the most immediate and active touchpoint for sensitive data, the endpoint plays a pivotal role in the data security ...

A wrist-worn, AI-driven transcutaneous peripheral nerve stimulator is linked to greater improvement in patients with ...

From vendors providing endpoint protection and detection tools to companies offering MDR, here’s a look at 20 key companies in endpoint and managed security. While endpoint security tools are no doubt ...

Moderna said its cytomegalovirus (CMV) vaccine didn't meet the primary efficacy endpoint in a Phase 3 trial, and it is discontinuing the clinical development program.

Endpoint security firm Igel has partnered with Palo Alto Networks on a secure access service edge (SASE) solution.